Innophore
Innophore provides tailor-made solutions for enzyme and drug discovery using its proprietary CatalophoreTM platform, which leverages 3D point-cloud technology to analyze protein active sites and surfaces. This approach allows for the identification of novel enzymes with improved properties and facilitates drug discovery and repurposing by going beyond traditional sequence and structural similarity searches. The company's technology is applied in biotechnology for industrial biocatalysis and in pharma for drug discovery, aiming to enhance R&D pipelines, reduce screening efforts, and accelerate time to market. Innophore utilizes high-performance supercomputing and cloud services from AWS and Google Cloud for its data mining and machine learning processes. The company is a spin-off of acib GmbH and the University of Graz, supported by Science Park Graz and strategic investor EOSS Industries GmbH.
Innophore
Innophore provides tailor-made solutions for enzyme and drug discovery using its proprietary CatalophoreTM platform, which leverages 3D point-cloud technology to analyze protein active sites and surfaces. This approach allows for the identification of novel enzymes with improved properties and facilitates drug discovery and repurposing by going beyond traditional sequence and structural similarity searches. The company's technology is applied in biotechnology for industrial biocatalysis and in pharma for drug discovery, aiming to enhance R&D pipelines, reduce screening efforts, and accelerate time to market. Innophore utilizes high-performance supercomputing and cloud services from AWS and Google Cloud for its data mining and machine learning processes. The company is a spin-off of acib GmbH and the University of Graz, supported by Science Park Graz and strategic investor EOSS Industries GmbH.